Nalanda India Equity Fund increased its Genpact holding by 1,015,556 shares worth approximately $43.92 million, signaling a bullish outlook. Despite a 27.3% year-over-year stock decline driven by AI obsolescence concerns, Genpact delivered 7% revenue growth in 2025 and expects similar growth in 2026 as it helps clients adopt AI. The stock's P/E ratio of 12 is at a one-year low, presenting a potentially attractive entry point.

The North America Business Process Outsourcing market is projected to grow from $112.96 billion in 2024 to $211.73 billion by 2033, driven by technological advancements, cost-saving needs, and digital transformation across industries.

Genpact announced a quarterly cash dividend of $0.17 per common share, payable on December 23, 2025, to shareholders of record as of December 9, 2025.

Genpact Limited, a global advanced technology services and solutions company, announced that its board of directors has declared a cash dividend of $0.17 per common share for the second quarter of 2025.

The global regulatory affairs outsourcing market is expected to grow significantly from 2024 to 2030, driven by the globalization of biopharmaceutical and medical device companies and the need for specialized regulatory expertise. Technological advancements in regulatory processes are also shaping the market.

The Industrial Services Market is projected to grow from $35.47 billion in 2023 to $65.76 billion by 2032, driven by the increasing adoption of Industry 4.0 technologies like IoT, AI, and advanced analytics in industrial systems.

The European pharmacovigilance and drug safety software market is expected to grow at a CAGR of 6.2% from 2023 to 2031, driven by the rise in adverse drug reactions, globalization of pharmacovigilance, and the integration of software with AI, ML, and NLP. Cloud-based platforms are a key market trend, enabling real-time monitoring and faster response to safety signals.

The global pharmaceutical regulatory affairs market is expected to reach $14.34 billion by 2030, driven by changes in regulatory landscape, growth in emerging areas, and entry of companies into the global market.

Genpact Limited announced that its board of directors has declared a cash dividend of $0.1525 per common share for the fourth quarter of 2024, payable on December 23, 2024 to shareholders of record as of December 9, 2024.

Accenture and Unilever have collaborated to leverage generative AI to enhance efficiency and operational agility across Unilever's digital infrastructure. The partnership aims to identify areas where AI can generate the most significant transformative impact, ultimately yielding higher returns on investment.

Corpay (CPAY) has had an impressive run over the past six months, with its shares gaining 10% against the industry's 1.6% decline. The company's earnings are expected to grow 12% in 2024 and 15.5% in 2025, driven by organic revenue growth and strategic acquisitions. The article also mentions Genpact (G) and Jamf (JAMF) as better-ranked stocks in the broader Zacks Business Services sector.

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.